Page last updated: 2024-10-20

uric acid and Encapsulating Peritoneal Sclerosis

uric acid has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, CY1
Han, J1
Zhang, CY1
Wu, K1
Lin, Y1

Other Studies

1 other study available for uric acid and Encapsulating Peritoneal Sclerosis

ArticleYear
UA promotes epithelial‑mesenchymal transition in peritoneal mesothelial cells.
    Molecular medicine reports, 2019, Volume: 20, Issue:3

    Topics: Cell Line; Cell Survival; Epithelial-Mesenchymal Transition; Epithelium; Humans; Kidney Failure, Chr

2019